Kleanthis G Xanthopoulos's Net Worth
$8.43 Million
Who is Kleanthis G Xanthopoulos?
Kleanthis G Xanthopoulos has an estimated net worth of $8.43 Million. This is based on reported shares across multiple companies, which include Zosano Pharma Corp, ISIS PHARMACEUTICALS INC, APRICUS BIOSCIENCES, INC., Regulus Therapeutics Inc., and ANADYS PHARMACEUTICALS INC.
SEC CIK
Kleanthis G Xanthopoulos's CIK is 0001283304
Past Insider Trading and Trends
2014 was Kleanthis G Xanthopoulos's most active year for acquiring shares with 17 total transactions. Kleanthis G Xanthopoulos's most active month to acquire stocks was the month of December. 2014 was Kleanthis G Xanthopoulos's most active year for disposing of shares, totalling 32 transactions. Kleanthis G Xanthopoulos's most active month to dispose stocks was the month of February. 2006 saw Kleanthis G Xanthopoulos paying a total of $106,200.00 for 36,000 shares, this is the most they've acquired in one year. In 2015 Kleanthis G Xanthopoulos cashed out on 880,000 shares for a total of $7,969,865.36, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Zosano Pharma Corp No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +174.50% | 15K |
—
|
—
| 23.6K |
Jun 10
| |||
Form 4
| +684.31% | 7.5K |
—
|
—
| 8.6K |
Jun 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 2
| |||
Form 4
| +265.33% | 15.92K |
$1.32 | $21,014.40 | 21.92K |
Aug 19
| |||
Form 4
|
∞
| 6K |
—
|
—
| 6K |
Apr 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ISIS PHARMACEUTICALS INC (IONS) Snapshot price: $46.89
President Regulus
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
APRICUS BIOSCIENCES, INC. (SEEL) Snapshot price: $0.2305
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 4
| |||
Form 4
| +156.66% | 15K |
—
|
—
| 24.57K |
Jan 5
| |||
Form 4
| +21.58% | 17K |
$0.34 | $5,750.09 | 95.75K |
Sep 30
| |||
Form 4
| +22.36% | 14.39K |
$0.40 | $5,750.00 | 78.75K |
Jun 30
| |||
Form 4
| +15.47% | 8.62K |
$0.58 | $5,000.18 | 64.36K |
Apr 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
| -23.57% | -17.18K |
$2.55 | -$43,819.20 | 55.73K |
Scheduled
|
Dec 26
| ||
Form 4
| -3.78% | -2.86K |
$2.52 | -$7,217.28 | 72.92K |
Scheduled
|
Jun 21
| ||
Form 4
| -3.64% | -2.86K |
$3.36 | -$9,612.73 | 75.78K |
Scheduled
|
May 21
| ||
Form 4
| -3.51% | -2.86K |
$2.63 | -$7,523.73 | 78.65K |
Scheduled
|
Apr 22
| ||
Form 4
| -3.39% | -2.86K |
$2.50 | -$7,160.00 | 81.51K |
Scheduled
|
Mar 21
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 7
| |||
Form 4
| -3.57% | -3.13K |
$3.25 | -$10,158.12 | 84.38K |
Scheduled
|
Sep 28
| ||
Form 4
| -12.50% | -12.50K |
$3.01 | -$37,683.75 | 87.5K |
Scheduled
|
Aug 15
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
|
∞
| 100K |
—
|
—
| 100K |
Nov 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Regulus Therapeutics Inc. (RGLS) Snapshot price: $1.48
President and CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$8.76 | -$3,353,496.79 | 3.71K |
Scheduled
|
Apr 17 - Apr 21
| ||
Form 4
|
—
|
0
|
$10.32 | -$1,774,155.21 | 2.47K |
Scheduled
|
Mar 5
| ||
Form 4
|
—
|
0
|
$9.94 | -$1,338.40 | 2.47K |
Scheduled
|
Feb 27
| ||
Form 4
|
—
|
0
|
$9.99 | -$109,625.40 | 2.47K |
Scheduled
|
Jan 30 - Feb 2
| ||
Form 4
|
—
|
0
|
$9.22 | -$2,564,049.57 | 2.47K |
Scheduled
|
Jan 28 - Jan 29
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 2
| |||
Form 4
|
—
|
0
|
$9.87 | -$66,492.00 | 2.47K |
Scheduled
|
Oct 29
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 20
| |||
Form 4
|
—
|
0
|
$3.70 | -$4,650.00 | 2.47K |
Scheduled
|
Oct 17 - Oct 20
| ||
Form 4
|
—
|
0
|
$3.69 | -$3,343.10 | 2.47K |
Scheduled
|
Oct 9 - Oct 14
| ||
Form 4
|
—
|
0
|
$3.70 | -$15,263.49 | 2.47K |
Scheduled
|
Sep 30
| ||
Form 4
|
—
|
0
|
$3.72 | -$23,422.51 |
0
|
Scheduled
|
Aug 28
| ||
Form 4
|
—
|
0
|
$3.72 | -$23,407.44 |
0
|
Scheduled
|
Aug 5
| ||
Form 4
|
—
|
0
|
$4.25 | -$27,093.65 |
0
|
Scheduled
|
Jul 1
| ||
Form 4
|
—
|
0
|
$3.76 | -$23,685.39 |
0
|
Scheduled
|
Jun 9
| ||
Form 4
|
—
|
0
|
$3.69 | -$23,205.98 |
0
|
Scheduled
|
May 27 - May 29
| ||
Form 4
|
—
|
0
|
$3.99 | -$25,291.03 | 80.22K |
Scheduled
|
Mar 6 - Apr 8
| ||
Form 4
|
—
|
0
|
$5.87 | -$38,446.35 | 80.22K |
Scheduled
|
Mar 6
| ||
Form 4
|
—
|
0
|
$4.39 | -$28,105.54 | 80.22K |
Scheduled
|
Feb 5
| ||
Form 4
|
—
|
0
|
$3.82 | -$24,076.55 | 80.22K |
Scheduled
|
Jan 2
| ||
Form 4
| -2.43% | -2.00K |
—
|
—
| 80.22K |
Dec 12 - Dec 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ANADYS PHARMACEUTICALS INC No price found
CEO and President
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 1
| |||
Form 4
| +3.81% | 6.5K |
$2.15 | $13,957.45 | 177.14K |
Aug 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4/A
| -2.85% | -5.00K |
—
|
—
| 170.64K |
Feb 5
| |||
Form 4
| -2.85% | -5.00K |
—
|
—
| 170.64K |
Feb 5
| |||
Form 4
| -0.06% | -100.00 |
$5.00 | -$500.00 | 175.64K |
Scheduled
|
Nov 14
| ||
Form 4
| -1.62% | -3.00K |
$4.97 | -$45,298.00 | 182.13K |
Scheduled
|
Jun 19
| ||
Form 4
| -2.72% | -5.00K |
$10.50 | -$52,514.28 | 178.74K |
Scheduled
|
May 15
| ||
Form 4
| -2.65% | -5.00K |
$14.86 | -$74,280.00 | 183.74K |
Scheduled
|
Apr 17
| ||
Form 4
| -2.58% | -5.00K |
$15.33 | -$76,654.00 | 188.74K |
Scheduled
|
Mar 20
| ||
Form 4
|
—
|
0
|
$8.82 | -$352,391.31 | 5.45K |
Mar 7
| |||
Form 4
| -100.00% | -6.14K |
$12.99 | -$79,752.55 |
0
|
Feb 28
| |||
Form 4
| -2.52% | -5.00K |
$11.81 | -$59,026.99 | 193.74K |
Scheduled
|
Feb 21
| ||
Form 4
| -2.45% | -5.00K |
$10.99 | -$54,952.94 | 198.74K |
Scheduled
|
Jan 17
| ||
Form 4
| -0.81% | -5.00K |
$8.16 | -$40,555.57 | 612.03K |
Scheduled
|
Dec 19
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 16
| |||
Form 4
| -2.34% | -5.00K |
$10.60 | -$52,989.57 | 208.74K |
Scheduled
|
Nov 21
| ||
Form 4
| -2.29% | -5.00K |
$10.93 | -$54,660.00 | 213.74K |
Scheduled
|
Oct 17
| ||
Form 4
| -2.23% | -5.00K |
$13.30 | -$66,505.50 | 218.74K |
Scheduled
|
Sep 19
| ||
Form 4
| -2.19% | -5.00K |
$12.85 | -$64,274.00 | 223.74K |
Scheduled
|
Aug 15
| ||
Form 4
| -2.14% | -5.00K |
$11.25 | -$56,243.00 | 228.74K |
Scheduled
|
Jul 18
| ||
Form 4
| -2.09% | -5.00K |
$8.72 | -$43,606.00 | 233.74K |
Scheduled
|
Jun 21
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||